Product Information
ALBUTEROL 2.5 MG/0.5 ML SOL is a generic product labeled by Nephron Pharmaceuticals Corporation, priced at $0.5158 per EA under NDC 00487990130. Its NADAC has been published 667 times since Nov 28, 2013.
FDA first approved this application on Jun 26, 2001. Its Orange Book therapeutic-equivalence code is AN.
Strength
2.5 mg/.5mL
Manufacturer
Nephron Pharmaceuticals CorporationNDC
00487990130
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ALBUTEROL SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA075664FDA Approved
6/26/2001
TE Code
AN
On Market Since
6/26/2001
Pharmacological Classes
Price Statistics
The NADAC for ALBUTEROL 2.5 MG/0.5 ML SOL has been published 667 times since Nov 28, 2013, and over the history we have for it it has risen 41.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5158 per EA |
|---|---|
| All-time high | $0.5292 (Aug 12, 2026) |
| All-time low | $0.3446 (Jul 20, 2016) |
| 52-week high | $0.5292 |
| 52-week low | $0.4406 |
| Median price | $0.3630 |
| Average price | $0.3819 |
| Largest weekly change | +26.8% (Dec 6, 2023) |
| Weeks tracked | 667 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nephron Pharmaceuticals Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Albuterol Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALBUTEROL 2.5 MG/0.5 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for ALBUTEROL 2.5 MG/0.5 ML SOL, manufactured by Nephron Pharmaceuticals Corporation, is $0.5158 per EA (NDC 00487990130), effective Sep 30, 2026.
How has the price of ALBUTEROL 2.5 MG/0.5 ML SOL changed over time?
Over the history we have for it, the NADAC for ALBUTEROL 2.5 MG/0.5 ML SOL has risen 41.4%. It has been tracked across 667 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALBUTEROL 2.5 MG/0.5 ML SOL?
Since Nov 28, 2013, the NADAC for ALBUTEROL 2.5 MG/0.5 ML SOL has ranged from a low of $0.3446 (Jul 20, 2016) to a high of $0.5292 (Aug 12, 2026), with a median of $0.3630 per EA.
Are there cheaper alternatives to ALBUTEROL 2.5 MG/0.5 ML SOL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALBUTEROL 2.5 MG/0.5 ML SOL, is $0.3616 per EA — about 30% below ALBUTEROL 2.5 MG/0.5 ML SOL.
Who manufactures ALBUTEROL 2.5 MG/0.5 ML SOL?
ALBUTEROL 2.5 MG/0.5 ML SOL (NDC 00487990130) is labeled by Nephron Pharmaceuticals Corporation, and CMS classifies it as a generic product.